SCHEMBL6187724

SCHEMBL6187724

CC(C)(C)OC(=O)N1CCC(Oc2ccc(N(Cc3nc4cc(C#N)ccc4n3CC(=O)O)C(=O)OCc3ccccc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.46
F10 P00742 15/20 0.46
PRMT5 O14744 1/20 0.40
ACSL1 P33121 1/20 0.40
ALK Q9UM73 1/20 0.39
CETP P11597 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6186844 0.91 F10 (0.56) GPR119F10
SCHEMBL6186841 0.91 F10 (0.56) GPR119F10
SCHEMBL6186585 0.85 F10 (0.53) GPR119F10CETP
SCHEMBL6186837 0.85 GPR119 (0.41) GPR119F10PRMT5ACSL1ALK
SCHEMBL6190950 0.84 GPR119 (0.56) GPR119F10ACSL1ALKCETP
SCHEMBL6186994 0.82 F10 (0.51) GPR119F10CETP
SCHEMBL6188847 0.81 GPR119 (0.53) GPR119F10ACSL1ALKCETP
SCHEMBL6191999 0.80 GPR119 (0.53) GPR119F10PRMT5ACSL1ALK
SCHEMBL6190762 0.78 F10 (0.64) GPR119F10CETP
SCHEMBL6190756 0.78 F10 (0.64) GPR119F10CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070714-A9 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2005-10-19 EP disclosed
US-20040006099-A1 Amidine compounds JAPAN TOBACCO INC. 2004-01-08 US disclosed
US-6562828-B1 Novel amidine compound having a blood coagulation factor Xa inhibitory activity JAPAN TOBACCO INC. (JP) 2003-05-13 US disclosed
EP-1070714-A1 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2001-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006099-A1 Amidine compounds F2, SERPINC1, F12 GPR119 2900/4885F10 16/4885PRMT5 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.